Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Planning pragmatic clinical trials for personalized immunotherapy in refractory cancers under HORIZON Europe project
| Reference number | 2026-01188 |
| Coordinator | Karolinska Institutet - Karolinska Institutet Instutionen för onkologi & patologi |
| Funding from Vinnova | SEK 499 961 |
| Project duration | May 2026 - September 2026 |
| Status | Ongoing |
| Call | Planning grant for international proposal 2026 |
Last updated 26 May 2026
Reference number 2026-01188
